This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

PARP

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What PARP Means in Everyday Medical Language

PARP stands for poly (ADP-ribose) polymerase, which is a group of enzymes found inside cells. These enzymes have an important job: they help repair damaged DNA. DNA is like the instruction manual for how cells grow and function. Damage to DNA can happen naturally as cells divide or from outside factors such as sunlight, radiation, or some cancer treatments. PARP enzymes work to fix this damage and keep cells healthy.

Why PARP Matters in Cancer Care

In cancer, PARP has become important because some cancer cells rely heavily on PARP enzymes, especially PARP-1, to repair their damaged DNA and survive. Certain drugs called PARP inhibitors block the activity of PARP-1. By doing this, these drugs make it harder for cancer cells to fix their DNA, which can help treatments like chemotherapy or radiation work better. This approach is being studied and used in some cancers, particularly when genetic changes like BRCA mutations are involved.

What Patients Might See or Hear About PARP

You might hear the term PARP or PARP inhibitors during discussions about your cancer treatment options, clinical trials, or drug information. Your doctor may talk about testing your tumor or genes to see if PARP inhibitors could be helpful. You might also see these terms in your medical reports or treatment plans. However, hearing about PARP does not mean you will automatically receive these drugs or that your cancer is caused by PARP-related problems. It is one part of understanding how cancer cells grow and how treatments might work.

Where PARP Appears in Your Care

PARP and PARP inhibitors may appear in treatment plans, clinical trial descriptions, or drug information sheets. They are often discussed when personalized treatment options are considered, especially if genetic testing shows certain mutations. Drugs like olaparib (Lynparza) and veliparib are examples of PARP inhibitors that may be used or studied for cancers such as breast, ovarian, prostate, and pancreatic cancers.

Common Questions to Ask Your Care Team

If PARP or PARP inhibitors come up in your care, you might ask: What role does PARP play in my cancer? Are PARP inhibitors an option for me? How do these drugs work? What are the possible benefits and side effects? Are there clinical trials involving PARP inhibitors that I might join? Understanding these points can help you feel more informed and confident in your care decisions.

Understanding PARP in Context

It’s important to remember that PARP is part of the cell’s natural repair system and not a test or diagnosis by itself. Not all cancers respond to PARP inhibitors, and their use depends on many factors unique to each person’s cancer and health. This information is educational and does not replace personalized advice from your healthcare providers. Your care team can explain how PARP fits into your overall treatment plan and what options might be available.

Next Steps for Patients and Caregivers

If you want to learn more about PARP or PARP inhibitors, the best step is to talk openly with your doctor or nurse. They can provide information tailored to your situation and help you understand how this fits into your care. Asking questions and seeking resources can empower you to make informed decisions about your treatment and feel more confident about the science behind some cancer therapies.

Sources

Public source information used for this glossary entry includes: